Price (delayed)
$4.29
Market cap
$55.71M
P/E Ratio
4.66
Dividend/share
N/A
EPS
$0.92
Enterprise value
$110.55M
Eagle Pharmaceuticals Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements
There are no recent dividends present for EGRX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.